| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | ISOX:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.025 | 0.5 |
| mRNA | regorafenib | CTRPv2 | pan-cancer | AAC | -0.027 | 0.5 |
| mRNA | GSK1070916 | GDSC1000 | pan-cancer | AAC | -0.022 | 0.5 |
| mRNA | Merck60 | CTRPv2 | pan-cancer | AAC | -0.022 | 0.5 |
| mRNA | XMD11-85h | GDSC1000 | pan-cancer | AAC | 0.034 | 0.5 |
| mRNA | ISOX | CTRPv2 | pan-cancer | AAC | -0.023 | 0.5 |
| mRNA | purmorphamine | CTRPv2 | pan-cancer | AAC | -0.027 | 0.5 |
| mRNA | GSK429286A | GDSC1000 | pan-cancer | AAC | 0.023 | 0.5 |
| mRNA | tandutinib | CTRPv2 | pan-cancer | AAC | -0.025 | 0.5 |
| mRNA | betulinic acid | CTRPv2 | pan-cancer | AAC | -0.027 | 0.5 |